New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance
By optimizing nature’s defenders, the team has produced unprecedented phage treatments
29-Jun-2023 -
The new biotech venturePHIOGENis a spin-off company fromBaylor College of Medicine’sTAILOR Labs, one of the United States only academic phage therapy cores with a decade’s worth of revolutionary research related to bacteriophages, viruses that infect and destroy bacteria.
The company made its ...
antibiotic resistance
antimicrobial resistance
bacteriophages
+1